2-38075247-G-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_000104.4(CYP1B1):​c.142C>G​(p.Arg48Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 1,593,196 control chromosomes in the GnomAD database, including 74,187 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. R48R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.36 ( 10687 hom., cov: 34)
Exomes 𝑓: 0.29 ( 63500 hom. )

Consequence

CYP1B1
NM_000104.4 missense

Scores

14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.744

Publications

177 publications found
Variant links:
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
CYP1B1-AS1 (HGNC:28543): (CYP1B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 35 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Trascript score misZ: -2.0997 (below the threshold of 3.09). GenCC associations: The gene is linked to Peters anomaly, anterior segment dysgenesis 6, glaucoma 3A, CYP1B1-related glaucoma with or without anterior segment dysgenesis, congenital glaucoma.
BP4
Computational evidence support a benign effect (MetaRNN=7.667002E-5).
BP6
Variant 2-38075247-G-C is Benign according to our data. Variant chr2-38075247-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92436.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.51 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000104.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP1B1
NM_000104.4
MANE Select
c.142C>Gp.Arg48Gly
missense
Exon 2 of 3NP_000095.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP1B1
ENST00000610745.5
TSL:1 MANE Select
c.142C>Gp.Arg48Gly
missense
Exon 2 of 3ENSP00000478561.1
CYP1B1
ENST00000490576.2
TSL:4
c.142C>Gp.Arg48Gly
missense
Exon 2 of 3ENSP00000478839.2
CYP1B1
ENST00000614273.1
TSL:5
c.142C>Gp.Arg48Gly
missense
Exon 2 of 3ENSP00000483678.1

Frequencies

GnomAD3 genomes
AF:
0.358
AC:
54437
AN:
152054
Hom.:
10663
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.516
Gnomad AMI
AF:
0.503
Gnomad AMR
AF:
0.323
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.367
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.287
Gnomad OTH
AF:
0.320
GnomAD2 exomes
AF:
0.312
AC:
67344
AN:
215506
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.516
Gnomad AMR exome
AF:
0.312
Gnomad ASJ exome
AF:
0.225
Gnomad EAS exome
AF:
0.190
Gnomad FIN exome
AF:
0.359
Gnomad NFE exome
AF:
0.289
Gnomad OTH exome
AF:
0.297
GnomAD4 exome
AF:
0.291
AC:
419924
AN:
1441022
Hom.:
63500
Cov.:
35
AF XY:
0.293
AC XY:
210007
AN XY:
715810
show subpopulations
African (AFR)
AF:
0.526
AC:
17549
AN:
33352
American (AMR)
AF:
0.311
AC:
13165
AN:
42288
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
5852
AN:
25768
East Asian (EAS)
AF:
0.148
AC:
5797
AN:
39198
South Asian (SAS)
AF:
0.370
AC:
31229
AN:
84480
European-Finnish (FIN)
AF:
0.357
AC:
16059
AN:
44926
Middle Eastern (MID)
AF:
0.328
AC:
1648
AN:
5018
European-Non Finnish (NFE)
AF:
0.281
AC:
310788
AN:
1106294
Other (OTH)
AF:
0.299
AC:
17837
AN:
59698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
19837
39674
59511
79348
99185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10438
20876
31314
41752
52190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.358
AC:
54510
AN:
152174
Hom.:
10687
Cov.:
34
AF XY:
0.362
AC XY:
26908
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.516
AC:
21434
AN:
41526
American (AMR)
AF:
0.322
AC:
4927
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
742
AN:
3470
East Asian (EAS)
AF:
0.181
AC:
936
AN:
5160
South Asian (SAS)
AF:
0.382
AC:
1842
AN:
4828
European-Finnish (FIN)
AF:
0.367
AC:
3895
AN:
10610
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.287
AC:
19501
AN:
67970
Other (OTH)
AF:
0.326
AC:
687
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1754
3509
5263
7018
8772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
869
Bravo
AF:
0.356
TwinsUK
AF:
0.258
AC:
957
ALSPAC
AF:
0.278
AC:
1071
ESP6500AA
AF:
0.506
AC:
2205
ESP6500EA
AF:
0.270
AC:
2313
ExAC
AF:
0.301
AC:
35804
Asia WGS
AF:
0.315
AC:
1094
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 14, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glaucoma 3A Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15958554, 11854439, 18573508, 10910054)

Anterior segment dysgenesis 6 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital glaucoma Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.7
DANN
Benign
0.40
DEOGEN2
Benign
0.12
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.10
T
MetaRNN
Benign
0.000077
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.74
PrimateAI
Benign
0.46
T
Sift4G
Benign
0.29
T
Vest4
0.030
ClinPred
0.000019
T
GERP RS
-4.8
Varity_R
0.070
gMVP
0.48
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10012; hg19: chr2-38302390; COSMIC: COSV53191035; COSMIC: COSV53191035; API